Sponsor pipeline

The First Hospital of Jilin University clinical trial pipeline

Get alerts when The First Hospital of Jilin University's trials change

73 active trials 30 recruiting 23 disease areas 11 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-09-22
Primary completion pushed: 2026-08-01 → 2026-12-01
Completion pushed: 2026-09-01 → 2026-12-20
NCT07454005 Innovative Probe With Laser on Radial Artery Puncture and Catheterisation in Paediatric
2026-09-04
Primary completion pushed: 2026-07-31 → 2026-12-31
Trial status changed: Enrolling by Invitation → Recruiting
NCT07178626 Association of Biomarkers and Gastric Antral Motility Index With Feeding Intolerance in…
2026-10-02
Trial completed
Final enrollment: 1351 participants (planned 779)
Primary completion confirmed: September 2026 (last estimated February 2027)
NCT07559721 Risk Factors and Predictive Model for Inflammatory Polyps in Ureteral Stones
2026-09-30
Recruitment opened
Interventions modified
NCT07346586 Tamsulosin for Early Catheter Removal After Rectal Cancer Surgery
2026-09-06
Trial status changed: Recruiting → Unknown
NCT06714903 Effect of Gut Microbiota and Its Metabolites on the Efficacy of Immunotherapy in…
2026-09-06
Trial status changed: Not Yet Recruiting → Unknown
NCT06045130 PUFAs in Preterm Infants

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-28 NCT07844512 Safety and Analgesic Efficacy of the Biased μ-Opioid Receptor Agonist Tegileridine for… Phase 3 Not Yet Recruiting
2026-09-28 NCT07844538 JLU_Nutr_FI Registry: A Prospective Registry of Feeding Intolerance in Critically Ill… Not Yet Recruiting
2026-09-11 NCT07815054 Efficacy Evaluation of Microwave Ablation Assisted by Diaphragm Hydrodissection for… Not Yet Recruiting
2026-09-08 NCT07806110 Gemcitabine and Albumin-Bound Paclitaxel Combined With Liposomal Irenotecan (II) With or… Phase 2 Active, Not Recruiting

Active trials by phase

Early Phase 1
1
Phase 1
1
Phase 1/2
1
Phase 2
14
Phase 2/3
1
Phase 3
1
Phase 4
5
Not charted: 49 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 73

NCT IDTitleConditionStatusUpdated
Phase 4
NCT07493824 Single-arm, Prospective Study of the Efficacy and Safety of Paiteling®Antibacterial… Persistent HR-HPV Infection of the Cervix Recruiting 2026-03-25
NCT07030894 Nefecon and Ambrisentan in IgA Nephropathy IgA Nephropathy Recruiting 2025-09-15
NCT07760610 Pomalidomide Plus Rituximab Maintenance in Young High-Risk Newly Diagnosed DLBCL After… Diffuse Large B-Cell Lymphoma (DLBCL) Not Yet Recruiting 2026-08-12
NCT07179913 The Improvement of Low-dose Esketamine on Postoperative Depression in Patients Undergoing… Depressed Active, Not Recruiting 2026-05-08
NCT06868017 Randomized Controlled Clinical Study of Efficacy and Safety of Initumab Combined with… HER2 Positive Breast Cancer Not Yet Recruiting 2025-03-10
Phase 3
NCT07844512 Safety and Analgesic Efficacy of the Biased μ-Opioid Receptor Agonist Tegileridine for… Pain Management Not Yet Recruiting 2026-09-28
Phase 2/3
NCT07505472 Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX… Rectal Cancer Recruiting 2026-04-01
Phase 2
NCT07400302 Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After… Mucosal Melanoma Recruiting 2026-09-03
NCT07559760 New Second-Line Combo Therapy for MSS Metastatic Colorectal Cancer Metastatic Colorectal Cancer Recruiting 2026-04-30
NCT07509086 IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell… Relapsed/Refractory Multiple Myeloma Recruiting 2026-04-03
NCT07119463 Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in… Postoperative Hypoalbuminemia Recruiting 2025-08-13
NCT06979908 A Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1… Metastatic Colorectal Cancer Recruiting 2025-05-20
NCT06875076 Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in… Pretreated Pleural Mesothelioma Recruiting 2025-03-13
NCT07806110 Gemcitabine and Albumin-Bound Paclitaxel Combined With Liposomal Irenotecan (II) With or… Pancreas Ductal Adenocarcinoma Active, Not Recruiting 2026-09-08
NCT07003464 Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy… Chronic Lymphocytic Leukemia Not Yet Recruiting 2025-06-04
NCT06550336 A Clinical Study Assessing the Efficacy of Chidamide for CD30-positive Peripheral T-cell… Peripheral T Cell Lymphoma Active, Not Recruiting 2024-08-29
NCT06574412 Cardenilimab Combined With Lenvatinib in Patients With Perioperative Resectable Clear… Resectable Clear Cell Carcinoma of the Kidney Not Yet Recruiting 2024-08-28
NCT06446206 Adebrelimab Plus Chemotherapy, Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed… Platinum-sensitive Relapsed Ovarian Cancer Not Yet Recruiting 2024-06-06
NCT04326153 Neoadjuvant Immunotherapy Plus Chemotherapy for Potentially Resectable Stage IIIA/IIIB… IIIA Stage Non-small Cell Lung Cancer Active, Not Recruiting 2024-02-01
NCT05998122 Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally… Locally Advanced Rectal Cancer Not Yet Recruiting 2023-08-18
NCT05784974 Cadonilimab Monotherapy as Neoadjuvant Therapy for Resectable II-IIIA Squamous Cell Lung… Lung Cancer Not Yet Recruiting 2023-03-27
Phase 1/2
NCT06592170 Linperlisib Combination With Obinutuzumab Frontline Treatment of Marginal Zone Lymphoma… Lymphoma Recruiting 2024-09-19
Phase 1
NCT07207681 Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors Advanced Solid Tumors Not Yet Recruiting 2025-10-06
Early Phase 1
NCT06525714 Effect of HIPEC After Radical Surgery on Long-term Survival for Locally Advanced Gastric… Gastric Cancer Not Yet Recruiting 2024-07-31
Not applicable
NCT07346586 Tamsulosin for Early Catheter Removal After Rectal Cancer Surgery Urinary Catheters Recruiting 2026-09-29
See all 73 active The First Hospital of Jilin University trials with filters →

Disease areas by active trials, top 10 of 23

Colorectal Cancer (7) · Gastric Cancer (6) · Liver Cancer (6) · Breast Cancer (4) · Ovarian Cancer (4) · Lung Cancer (3) · Leukemia (2) · Non-Hodgkin Lymphoma (2) · Chronic Kidney Disease (1) · Chronic Lymphocytic Leukemia (CLL) (1)

Get alerts when The First Hospital of Jilin University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free